Scleroderma [7]

New England Journal of Medicine

Volumn 361, Issue 8, 2009, Pages 826-827

  Demoulin, Jean Baptiste ^a   Kämpe, Olle ^b   Rorsman, Fredrik ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; BLOOD SAMPLING; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; PRIORITY JOURNAL; SCLERODERMA; BLOOD; IMMUNOLOGY; NOTE; SYSTEMIC SCLEROSIS;

AUTOANTIBODIES; HUMANS; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SCLERODERMA, SYSTEMIC;

EID: 69049107548     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc091209     Document Type: Letter

References (4)

1. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009;360:1989-2003.
2. Baroni SS, Santillo M, Bevilacqua F, et al. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006;354:2667-76.
3. Classen JF, Henrohn D, Rorsman F, et al. Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis. Arthritis Rheum 2009;60:1137-44.
4. Loizos N, Lariccia L, Weiner J, et al. Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera. Arthritis Rheum 2009;60:1145-51.